Medication Activates Dormant Bone Cells to Ease Lower Back Discomfort
Navitoclax knocked out pain-triggering senescent osteoclasts to relieve back painDepositphotosIn positive developments for the 80% of Americans experiencing lower back pain during their lifetime, scientists have discovered that repurposing an existing drug can effectively target dormant osteoclast cells, reducing spinal hypersensitivity.Xu Cao, a senior author and Orthopedic Surgery professor at Johns Hopkins University School...